Literature DB >> 32695631

An analysis of the correlation between the human apolipoprotein E gene polymorphism and lipoprotein-associated phospholipase A2.

Wei-Guo Yin1, Peng Zhou1, Xiao-Hong Zhou2, Yan-Mei Liu1, Chen Chen1, Shu-Xia Xuan1, Bin Cheng1, Jin-Duan Lin1, Ling-Qing Xu3.   

Abstract

BACKGROUND: Atherosclerosis is one of the most common cardiovascular and cerebrovascular diseases. This study aimed to explore the correlation between gene polymorphism of human apolipoprotein E (ApoE) and lipoprotein-associated phospholipase A2 (Lp-PLA2).
METHODS: A total of 220 patients with atherosclerotic cardiovascular disease who were treated in our hospital from June 2016 to March 2017 were enrolled in this study and assigned as the atherosclerotic cardiovascular disease group and 193 patients who were treated contemporaneously in our hospital but had no atherosclerotic cardiovascular disease were enrolled and assigned as the control group. Gene polymorphism of ApoE was detected by PCR-fluorescent probe technique and the level of Lp-PLA2 was detected by ELISA.
RESULTS: There were a total of 5 genotypes of ApoE in these two groups, which were E2/3, E3/3, E3/4, E2/4, and E4/4. E2/2 was not found in any of the patients. E3/3 made up the majority in both groups. There was no significant difference between the proportion of genotypes and frequencies of alleles in the two groups (P>0.05). There was no difference between LP-PLA2 among the different genotypes in these two groups (P>0.05).
CONCLUSIONS: We cannot conclude that ApoE gene polymorphism is related to atherosclerotic cardiovascular and cerebrovascular diseases. And it cannot be concluded that ApoE gene polymorphism is related to Lp-PLA2 level. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Apolipoprotein E; atherosclerosis; correlation; gene polymorphism; lipoprotein-associated phospholipase A2

Year:  2020        PMID: 32695631      PMCID: PMC7369275          DOI: 10.21037/cdt-20-43

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  21 in total

Review 1.  Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis.

Authors:  Morteza Abyadeh; Kurosh Djafarian; Fatemeh Heydarinejad; Shahab Alizadeh; Sakineh Shab-Bidar
Journal:  J Mol Neurosci       Date:  2019-08-23       Impact factor: 3.444

Review 2.  Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

Authors:  Andrew Zalewski; Colin Macphee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

Review 3.  Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Authors:  Narendra S Choudhary; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 4.  The role of APOE on lipid homeostasis and inflammation in normal brains.

Authors:  G William Rebeck
Journal:  J Lipid Res       Date:  2017-03-02       Impact factor: 5.922

Review 5.  Evolution of human apolipoprotein E (APOE) isoforms: Gene structure, protein function and interaction with dietary factors.

Authors:  Patricia Huebbe; Gerald Rimbach
Journal:  Ageing Res Rev       Date:  2017-06-21       Impact factor: 10.895

Review 6.  Apoprotein E and Reverse Cholesterol Transport.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

7.  Lipoprotein-Associated Phospholipase A2 Activity and Mass as Independent Risk Factor of Stroke: A Meta-Analysis.

Authors:  Gaifeng Hu; Deping Liu; Huiyu Tong; Weijun Huang; Yunzhao Hu; Yuli Huang
Journal:  Biomed Res Int       Date:  2019-05-20       Impact factor: 3.411

8.  Carotid artery color Doppler ultrasonography and plasma levels of lipoprotein-associated phospholipase A2 and cystatin C in arteriosclerotic cerebral infarction.

Authors:  Lei Huang; Shengguo Yao
Journal:  J Int Med Res       Date:  2019-07-25       Impact factor: 1.671

9.  Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and Assessment.

Authors:  Shuzhen Zhu; Xiaobo Wei; Xiaohua Yang; Zifeng Huang; Zihan Chang; Fen Xie; Qin Yang; Changhai Ding; Wei Xiang; Hongjun Yang; Ying Xia; Zhong-Ping Feng; Hong-Shuo Sun; Midori A Yenari; Lin Shi; Vincent Ct Mok; Qing Wang
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

10.  Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement.

Authors:  Dongdan Zheng; FanFang Zeng; Anping Cai; Huocheng Liao; Ling Liu; Ruofeng Qiu; Rulin Xu; Chun Xiao; Weiyi Mai
Journal:  Lipids Health Dis       Date:  2014-03-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.